Indrayani Biotech has informed that at the meeting of Board of Directors held today on Wednesday, October 07, 2026, the Directors have recorded the following: The approval of Unaudited Financial Results (Standalone and Consolidated) of the Company, for the quarter ended June 30, 2026, as recommended by the Audit Committee at their Meeting held today, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The statutory auditors have reviewed the financial results and given unmodified opinion; Approved the reconstitution of the following Committees of the Board with effect from today, 07th October, 2026.
The above information is a part of company’s filings submitted to BSE.
